Pitches · 8:00–9:30 AM PT
OrthoPreserve
Jonathan Schwartz, CEO · jschwartz@orthopreserve.com
OrthoPreserve's minimally invasive, artificial meniscus implant restores knee function and preserves joint health.
Round
$2M Convertible Note @ $8M pre money valuation cap
Closed
$1.2M
FDA milestone
FDA Breakthrough Device Designation and TAP enrollment, with Q-sub for GLP animal study protocol
FDA timeline
4-4.5 years
Other groups in round
ATA, Georgia Tech Foundation Venture Fund, Fund That Tiger VC
DD package
yes
Traction: Traction through strong third-party validation and early commercial readiness: NIH SBIR grant, selection into 3 competitive medtech accelerators and 1st/finalist in 3 startup award competitions; partnership with CDMO, endorsements from experienced orthopedic surgeons, and validation of fit within existing reimbursement codes from top consultants
What they're looking for: We'd love to connect with more KOLs and experienced Medtech advisors
Round
$1M Priced Round @ $10M
Closed
$180K
FDA milestone
N/A
FDA timeline
N/A
Other groups in round
Angels
DD package
No
Traction: $600K
What they're looking for: Customer Intros
IonDX, Inc.
Luis Carbonell, CEO · lcarbonell@iondx.com
Sample preparation intstrumentation for cryo electron microscopy
Round
$1.5M Priced Round @ $5.9M pre-money
Closed
$450K
FDA milestone
N/A, life sciences research instrumentation
FDA timeline
N/A, life sciences research instrumentation
Other groups in round
Agilent, Thiel Foundation
DD package
not yet but will be available shortly
Traction: Collaborations with Genentech & Scripps
What they're looking for: Looking for support in raising our seed round